melanotan-2 injection: Frequently asked questions

This signals localized immune activation. Your body interpreted the injection as mild trauma and deployed inflammatory cytokines (IL-1β, TNF-α) to the site. Apply a cold compress for 10 minutes immediately post-injection to reduce vasodilation. If redness persists beyond 48 hours or spreads beyond 2 cm from the injection point, stop using that site entirely for 7 days. Persistent inflammation suggests you're reusing sites too frequently or injecting too rapidly. Both errors compound tissue trauma.

Use the anterior thigh as your primary site. Individuals with very low body fat (under 10–12% for men, under 18–20% for women) may have insufficient abdominal subcutaneous tissue for reliable depot formation. The anterior thigh typically retains more subcutaneous fat even in lean individuals due to its role in cushioning and insulation. Pinch the skin firmly. If you can grasp a fold of at least 1 inch, subcutaneous injection is feasible. Switch to a 5/16-inch needle instead of 1/2-inch to reduce intramuscular penetration risk.

This is lipohypertrophy. Localized fatty tissue buildup caused by repeated injections at the same location. Stop using that site immediately and rotate to a different area. The lump typically resolves over 4–8 weeks without intervention as the tissue remodels. Lipohypertrophy occurs when injection trauma stimulates adipocyte proliferation faster than the tissue can heal between injections. Prevention requires strict rotation: wait at least 5–7 days before reusing the same 1-inch area. If lumps persist beyond two months or feel firm and painful, consult a healthcare provider. Though rare, subcutaneous nodules can indicate sterile abscess formation from contamination.

You're likely injecting too shallow (intradermally rather than subcutaneously) or too close to the umbilicus where fascia sits closer to the skin. Pinch a fold of abdominal skin 2–3 inches lateral to your navel. Insert the needle at a 45–90 degree angle into the pinched fold, aiming for the subcutaneous fat layer beneath the dermis. If you can feel resistance or the needle seems to 'scrape' against something, you've gone too deep toward muscle fascia. Withdraw slightly and redirect. The ideal depth for subcutaneous MT-2 injection is 4–8 mm below the skin surface.

You're either injecting perpendicular instead of at 45 degrees, failing to pinch the skin, or choosing sites with insufficient fat depth. Correct technique: pinch a skin fold firmly between thumb and forefinger, insert the needle at a 45-degree angle into the fold (not perpendicular to the body surface), and inject slowly. If you consistently feel resistance or experience sharp pain during injection, you're likely penetrating muscle fascia. Move to a site with more subcutaneous fat. The lateral abdomen or anterior thigh. And reduce needle length to 5/16 inch maximum.

Increase dilution to 3:1 (3 mL bacteriostatic water per 10 mg vial). This creates a 3.33 mg/mL solution. Well below the osmolarity threshold that triggers tissue water influx. The trade-off: you'll inject a larger volume per dose (0.3 mL for a 1 mg dose instead of 0.2 mL), but the osmotic gradient decreases proportionally. Researchers using 3:1 ratios report near-complete elimination of the 'burn' sensation, though injection time extends slightly due to increased volume.